Literature DB >> 7286972

The mechanism of metastasis in the so-called "benign giant cell tumor of bone".

R L Caballes.   

Abstract

A case of so-called "benign giant cell tumor of bone" with an incidental histologic finding of intratumor vascular invasion is reported. The mechanism and biology of metastasis are briefly discussed. For the purposes of this presentation, the mechanism of metastasis is divided into two types--active and passive. An active type of metastasis indicates malignancy, whereas a passive type denotes a benign process. The malignant features of the conventional or typical giant cell tumor of bone are demonstrated. It is proposed that this neoplasm be labeled malignant despite its seemingly benign histologic appearance. Relative to the degree of malignancy, a lesion of this nature may be classified as either a low or a high grade type of malignant giant cell tumor.

Entities:  

Mesh:

Year:  1981        PMID: 7286972     DOI: 10.1016/s0046-8177(81)80182-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Prognostic factors in giant cell tumor of bone. A modified histological grading system useful as a guide to prognosis.

Authors:  S Komiya; A Inoue; M Nakashima; A Ueno; K Fujikawa; H Ikuta
Journal:  Arch Orthop Trauma Surg       Date:  1986

2.  GIANT CELL TUMOUR OF BONE: AN UNUSUAL METASTATIC PATTERN: A Case Report.

Authors:  V P Singh; N Kannan; H G Mukhopadhyay; S Mukherjee; R Lakhtakia
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Expression and localization of urokinase-type plasminogen activator in human spinal column tumors.

Authors:  Z L Gokaslan; S K Chintala; J E York; V Boyapati; S Jasti; R Sawaya; G Fuller; D M Wildrick; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

4.  Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.

Authors:  V H Rao; R K Singh; J A Bridge; J R Neff; G B Schaefer; D C Delimont; C M Dunn; W G Sanger; B A Buehler; R Sawaya; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.

Authors:  V H Rao; J A Bridge; J R Neff; G B Schaefer; B A Buehler; J K Vishwanatha; R E Pollock; G L Nicolson; M Yamamoto; Z L Gokaslam
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

6.  Cementation in the treatment of giant cell tumor of bone.

Authors:  S Komiya; A Inoue
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

7.  Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities?

Authors:  Seethalakshmi Viswanathan; N A Jambhekar
Journal:  Clin Orthop Relat Res       Date:  2009-07-14       Impact factor: 4.176

8.  Benign giant-cell tumours of bone with pulmonary metastases and favourable prognosis. Report on two cases and review of the literature.

Authors:  D Vanel; G Contesso; G Rebibo; B Zafrani; J Masselot
Journal:  Skeletal Radiol       Date:  1983       Impact factor: 2.199

9.  Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.

Authors:  Y Ueda; K Imai; H Tsuchiya; N Fujimoto; I Nakanishi; S Katsuda; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

10.  Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone.

Authors:  Y Sasaguri; S Komiya; K Sugama; K Suzuki; A Inoue; M Morimatsu; H Nagase
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.